WallStreetZenWallStreetZen

NASDAQ: SABS
Sab Biotherapeutics Inc Stock Ownership - Who owns Sab Biotherapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Sab Biotherapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Eddie Joe SullivanChief Executive Officer2023-12-071,740$0.88
$1.53kBuy
Michael KingCHIEF FINANCIAL OFFICER2023-11-305,000$0.90
$4.50kBuy
Samuel J. ReichExecutive Chairman2023-11-2911,000$0.90
$9.85kBuy

1 of 1

SABS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SABS insiders and whales buy or sell their stock.

SABS Shareholders

What type of owners hold Sab Biotherapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Christine E. Hamilton121.81%11,237,694$47.76MInsider
Edward D. Hamilton108.65%10,023,848$42.60MInsider
Rtw Investments LP99.49%9,178,282$39.01MInstitution
Bvf Inc99.49%9,178,282$39.01MInstitution
Ilan Katz66.09%6,097,150$25.91MInsider
Eddie Joe Sullivan56.72%5,232,304$22.24MInsider
Marshall Wace LLP49.70%4,585,282$19.49MInstitution
Sessa Capital Im LP49.69%4,584,571$19.48MInstitution
Andrew Moin49.69%4,584,571$19.48MInsider
Sessa Capital Master LP49.69%4,584,571$19.48MInsider

1 of 3

SABS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SABS40.51%59.49%Net Buying
MTNB11.76%13.73%
ICCC13.45%24.31%Net Buying
OCUP1.23%98.77%Net BuyingNet Buying
CTCX11.98%59.11%Net Buying
View Top Biotech Stocks

Sab Biotherapeutics Stock Ownership FAQ

Who owns Sab Biotherapeutics?

Sab Biotherapeutics (NASDAQ: SABS) is owned by 385.78% institutional shareholders, 566.59% Sab Biotherapeutics insiders, and 0.00% retail investors. Christine E. Hamilton is the largest individual Sab Biotherapeutics shareholder, owning 11.24M shares representing 121.81% of the company. Christine E. Hamilton's Sab Biotherapeutics shares are currently valued at $47.76M.

If you're new to stock investing, here's how to buy Sab Biotherapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.